{"id":"https://openalex.org/W2000497085","doi":"https://doi.org/10.1093/neuonc/nou174.385","title":"P17.56 * A 3-DIMENSIONAL MATRIX ASSAY TO HELP PREDICT TREATMENT RESPONSE TO TEMOZOLOMIDE IN PATIENTS WITH GLIOBASTOMA: UPDATE OF RESULTS AND SUBGROUP ANALYSIS OF PATIENTS UNDERGOING MGMT TESTING","display_name":"P17.56 * A 3-DIMENSIONAL MATRIX ASSAY TO HELP PREDICT TREATMENT RESPONSE TO TEMOZOLOMIDE IN PATIENTS WITH GLIOBASTOMA: UPDATE OF RESULTS AND SUBGROUP ANALYSIS OF PATIENTS UNDERGOING MGMT TESTING","alternate_titles":[],"publication_year":2014,"publication_date":"2014-09-01","ids":{"openalex":"https://openalex.org/W2000497085","doi":"https://doi.org/10.1093/neuonc/nou174.385","mag":"2000497085","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4185755"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/nou174.385","doi":"https://doi.org/10.1093/neuonc/nou174.385","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nou174.385","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000497085"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4185755/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049280146","display_name":"Joseph F. Megyesi","orcid":"https://orcid.org/0000-0002-5653-1455","observed_orcids":["https://orcid.org/0000-0002-5653-1455"]},"institutions":[{"id":"https://openalex.org/I125749732","display_name":"Western University","ror":"https://ror.org/02grkyz14","country_code":"CA","type":"education","lineage":["https://openalex.org/I125749732"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. F. Megyesi","raw_affiliation_strings":["University of Western Ontario, London, ON, Canada","1University of Western Ontario, London, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Western Ontario, London, ON, Canada","institution_ids":["https://openalex.org/I125749732"]},{"raw_affiliation_string":"1University of Western Ontario, London, ON, Canada","institution_ids":["https://openalex.org/I125749732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113639760","display_name":"P. Costello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125749732","display_name":"Western University","ror":"https://ror.org/02grkyz14","country_code":"CA","type":"education","lineage":["https://openalex.org/I125749732"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Costello","raw_affiliation_strings":["University of Western Ontario, London, ON, Canada","1University of Western Ontario, London, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Western Ontario, London, ON, Canada","institution_ids":["https://openalex.org/I125749732"]},{"raw_affiliation_string":"1University of Western Ontario, London, ON, Canada","institution_ids":["https://openalex.org/I125749732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085175271","display_name":"Warren McDonald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125749732","display_name":"Western University","ror":"https://ror.org/02grkyz14","country_code":"CA","type":"education","lineage":["https://openalex.org/I125749732"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. McDonald","raw_affiliation_strings":["University of Western Ontario, London, ON, Canada","1University of Western Ontario, London, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Western Ontario, London, ON, Canada","institution_ids":["https://openalex.org/I125749732"]},{"raw_affiliation_string":"1University of Western Ontario, London, ON, Canada","institution_ids":["https://openalex.org/I125749732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111959128","display_name":"David R. Macdonald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125749732","display_name":"Western University","ror":"https://ror.org/02grkyz14","country_code":"CA","type":"education","lineage":["https://openalex.org/I125749732"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Macdonald","raw_affiliation_strings":["University of Western Ontario, London, ON, Canada","1University of Western Ontario, London, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Western Ontario, London, ON, Canada","institution_ids":["https://openalex.org/I125749732"]},{"raw_affiliation_string":"1University of Western Ontario, London, ON, Canada","institution_ids":["https://openalex.org/I125749732"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031998230","display_name":"Jacob C. Easaw","orcid":"https://orcid.org/0000-0001-5270-1050","observed_orcids":["https://orcid.org/0000-0001-5270-1050"]},"institutions":[{"id":"https://openalex.org/I168635309","display_name":"University of Calgary","ror":"https://ror.org/03yjb2x39","country_code":"CA","type":"education","lineage":["https://openalex.org/I168635309"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Easaw","raw_affiliation_strings":["University of Calgary, Calgary, AB, Canada","2University of Calgary, Calgary, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Calgary, Calgary, AB, Canada","institution_ids":["https://openalex.org/I168635309"]},{"raw_affiliation_string":"2University of Calgary, Calgary, AB, Canada","institution_ids":["https://openalex.org/I168635309"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"suppl 2","first_page":"ii100","last_page":"ii100"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.7929999828338623},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.8059999942779541},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.6269999742507935},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.7540000081062317},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.45100000500679016},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.5180000066757202},{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.8650000095367432},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.7229999899864197},{"id":"https://openalex.org/keywords/tumor-tissue-culture","display_name":"tumor tissue culture","score":0.33000001311302185},{"id":"https://openalex.org/keywords/drug-susceptibility-testing","display_name":"drug susceptibility testing","score":0.5519999861717224},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.5590000152587891},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.9944693446159363},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7748655080795288},{"id":"https://openalex.org/C2780964509","wikidata":"https://www.wikidata.org/wiki/Q416975","display_name":"Dacarbazine","level":3,"score":0.6422808170318604},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5773985385894775},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.5633995532989502},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5527809262275696},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5513229966163635},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5296366214752197},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.5276196002960205},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4833931028842926},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2177373170852661},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.08783647418022156}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/nou174.385","doi":"https://doi.org/10.1093/neuonc/nou174.385","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nou174.385","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4185755","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4185755/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4185755","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4185755/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1994689818","https://openalex.org/W2983906378","https://openalex.org/W4200199881","https://openalex.org/W4240141338","https://openalex.org/W2553699491","https://openalex.org/W2312989970","https://openalex.org/W2000039301","https://openalex.org/W2155524619","https://openalex.org/W1998472924","https://openalex.org/W2899685011"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Usual":[1],"treatment":[2,327],"for":[3,79,100,103,126,135,252,273],"glioblastoma":[4,108,204,231,321],"is":[5],"surgical":[6,40,115],"resection,":[7],"if":[8],"possible,":[9],"followed":[10],"by":[11],"radiotherapy":[12],"with":[13,87,189,203,230,233],"adjuvant":[14],"chemotherapy":[15],"using":[16],"temozolomide.":[17,57,97,175,199,330],"However":[18],"a":[19,25,32,65,74,129,149,169,180,211,228,303,326,335],"significant":[20],"number":[21],"of":[22,46,76,90,122,156,179,182,192,227,238,297,349],"patients":[23,78,101,112,163,184,202,253,274,291,300,322],"have":[24],"short":[26],"response":[27,89,173,191,215,237,307,328,340],"to":[28,54,60,96,152,174,198,243,260,280,329,333,345],"temozolomide":[29,161,234,244,261,281],"and":[30,84,117,133,137,144,187,214,235,311],"subsequently":[31],"poorer":[33],"prognosis.":[34],"We":[35,72,217],"investigated":[36],"the":[37,44,88,94,190,196,222,225,236,246,263,283,298,309,339,343,346,350],"possibility":[38],"that":[39,69,239],"specimens":[41,119],"obtained":[42],"at":[43,120,221],"time":[45,121,251,272],"surgery":[47,123],"might":[48],"provide":[49],"valuable":[50],"information":[51],"regarding":[52],"sensitivity":[53],"chemotherapies,":[55],"including":[56],"In":[58,295],"order":[59],"do":[61],"this":[62,86],"we":[63],"used":[64],"3-dimensional":[66,130,247,316],"matrix":[67,131],"assay":[68,95,132,197,264,284,310,317,344],"mimics":[70],"brain.":[71],"analyzed":[73,186],"subgroup":[75,181],"these":[77,183],"O-6-methylguanine-DNA":[80],"methyltransferase":[81],"(MGMT)":[82],"status":[83,178,348],"correlated":[85,188],"tumor":[91,118,193,209,241,306],"tissue":[92,194,242],"in":[93,128,195,219,245,262,282,308,342],"METHODS:":[98],"Records":[99],"treated":[102,162,232],"newly":[104],"diagnosed":[105],"or":[106,171],"recurrent":[107],"were":[109,124,146,205,256,277],"analyzed.":[110],"All":[111],"had":[113,167],"undergone":[114],"resection":[116],"available":[125],"culture":[127],"observed":[134],"growth":[136,145],"invasion.":[138],"Drug":[139],"effects":[140],"on":[141],"mean":[142],"invasion":[143,213],"expressed":[147],"as":[148],"ratio":[150],"relative":[151],"control":[153],"conditions.":[154],"Length":[155],"survival":[157,250,271],"was":[158,185,265,285,302],"compared":[159],"between":[160,224,305,338],"whose":[164,254,275],"screening":[165],"results":[166],"predicted":[168],"positive":[170,336],"negative":[172],"The":[176,315],"MGMT":[177,293,312,347],"RESULTS:":[200],"Fifty-eight":[201],"assessed.":[206],"Each":[207],"patient's":[208,240,351],"displayed":[210],"unique":[212],"profile.":[216],"looked":[218],"particular":[220],"correlation":[223,304,337],"outcome":[226],"patient":[229],"assay.":[248],"Mean":[249,270],"tumors":[255,276],"not":[257],"significantly":[258,278],"sensitive":[259,279],"181.7":[266],"+/-":[267,287],"43":[268],"days.":[269,289],"290.0":[286],"33":[288],"Twelve":[290],"underwent":[292],"testing.":[294],"10":[296],"12":[299],"there":[301],"status.":[313],"CONCLUSION:":[314],"may":[318],"help":[319],"predict":[320],"who":[323],"will":[324],"show":[325],"There":[331],"appears":[332],"be":[334],"profiles":[341],"tumor.":[352]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000497085","counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2016-06-24T00:00:00"}
